Accera Inc, the Singapore-headquartered pharmaceutical company, has announced the first close of its $50 million-investment round led by Wilmar Ventures, a wholly-owned subsidiary of Wilmar International Ltd.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
